IMR Press / FBL / Volume 12 / Issue 8 / DOI: 10.2741/2291

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Multiplex ligation-dependent probe amplification (MLPA) genotyping assay for mouse models of down syndrome
Show Less
1 The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
2 Department of Medical Biology, The University of Melbourne, Australia
3 Monash Institute of Medical Research, Monash University, Victoria, Australia
Front. Biosci. (Landmark Ed) 2007, 12(8), 3010–3016;
Published: 1 May 2007

The Ts65Dn mouse is the most widely investigated segmentally trisomic mouse model of Down syndrome. Quantitative PCR based methods are the preferred way of detecting the trisomic segment for genotyping purposes. However, identification of a 1.5 fold difference in target DNA is at the limit of detection of most quantitative PCR based methods, and in practice this can lead to difficulties in assigning genotypes. We report a 100% accurate multiplex ligation-dependent probe amplification (MLPA) assay for genotyping the Ts65Dn mouse that is also applicable to all other segmentally trisomic mouse models of Down syndrome.

Back to top